西向有沙 (ARISA NISHIMUKAI) - マイポータル

Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.

Ayumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, Aoi Oshiro, Yusa Togashi, Akira Hattori, Junko Tsuchida, Tomoko Higuchi, Arisa Nishimukai, Keiko Murase …

International journal of clinical oncology 29(12) 1850-1859 2024年12月

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.

Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Arisa Nishimukai, Kaori Takamoto, Takashi Morimoto, Yuichiro Kikawa, Hirofumi Suwa …

Oncotarget 11(1) 86-98 2020年1月7日

Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.

Yoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, Hiromi Ozawa, Yukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, Ayako Kira, Michiko Imamura, Yuichi Takatsuka …

Clinical breast cancer 18(5) 400-409 2018年10月

High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.

Yukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, Yoshimasa Miyagawa, Ayako Kira, Hiromi Ozawa, Ayako Bun, Michiko Imamura, Yasuo Miyoshi

Journal of surgical oncology 118(1) 228-237 2018年7月

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

Michiko Imamura, Takashi Morimoto, Takashi Nomura, Shintaro Michishita, Arisa Nishimukai, Tomoko Higuchi, Yukie Fujimoto, Yoshimasa Miyagawa, Ayako Kira, Keiko Murase …

World journal of surgical oncology 16(1) 26-26 2018年2月12日

Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.

Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yuichi Takatsuka, Yasuo Miyoshi

Breast cancer (Tokyo, Japan) 24(2) 245-253 2017年3月

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

Arisa Nishimukai, Natsuko Inoue, Ayako Kira, Masashi Takeda, Koji Morimoto, Kazuhiro Araki, Kazuhiro Kitajima, Takahiro Watanabe, Seiichi Hirota, Toyomasa Katagiri …

PloS one 12(9) e0184508 2017年

Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes.

Tomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, Yukie Fujimoto, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yuichi Takatsuka, Kazuhiro Kitajima …

Breast (Edinburgh, Scotland) 30 5-12 2016年12月

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.

Yukie Enomoto, Takashi Morimoto, Arisa Nishimukai, Tomoko Higuchi, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yuichi Takatsuka, Takashi Nomura …

International journal of clinical oncology 21(2) 254-261 2016年4月

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.

Tomoko Yagi, Natsuko Inoue, Ayako Yanai, Keiko Murase, Michiko Imamura, Yoshimasa Miyagawa, Yukie Enomoto, Arisa Nishimukai, Yuichi Takatsuka, Seiichi Hirota …

Breast cancer (Tokyo, Japan) 23(2) 224-30 2016年3月

High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.

Michiko Imamura, Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Isao Sakita, Takuya Hatada, Yuichi Takatsuka …

Breast cancer research and treatment 154(3) 521-31 2015年12月

Association between ¹⁸F-FDG uptake and molecular subtype of breast cancer.

Kazuhiro Kitajima, Kazuhito Fukushima, Yasuo Miyoshi, Arisa Nishimukai, Seiichi Hirota, Yoko Igarashi, Takayuki Katsuura, Kaoru Maruyama, Shozo Hirota

European journal of nuclear medicine and molecular imaging 42(9) 1371-7 2015年8月

High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.

Arisa Nishimukai, Tomoko Yagi, Ayako Yanai, Yoshimasa Miyagawa, Yukie Enomoto, Keiko Murase, Michiko Imamura, Yuichi Takatsuka, Isao Sakita, Takuya Hatada …

Clinical breast cancer 15(3) 204-11 2015年6月

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.

Ayako Yanai, Natsuko Inoue, Tomoko Yagi, Arisa Nishimukai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yukie Enomoto, Yuichi Takatsuka, Takahiro Watanabe …

Clinical breast cancer 15(3) 197-203 2015年6月

Association of FDG uptake with molecular subtypes of breast cancer

Kazuhiro Kitajima, Kazuhito Fukushima, Yasuo Miyoshi, Arisa Nishimukai, Toshiko Yamano, Takayuki Katsuura, Yoko Igarashi, Kaoru Maruyama, Kumiko Ando, Shozou Hirota

JOURNAL OF NUCLEAR MEDICINE 56(3) 2015年5月

HER2陽性乳がん薬物治療 : 治療を完遂するための工夫(1)耐性機序を考慮した抗HER2薬の選択

西向有沙, 三好康雄

臨床腫瘍プラクティス = The practice of medical oncology 9(3) 330-335 2013年

Two giant renal aneurysms and renal arteriovenous fistula associated with cardiac insufficiency and a sustained elevation of atrial natriuretic peptide and brain natriuretic peptide.

Tsuyoshi Sakoda, Arisa Nishimukai, Takeshi Tsujino, Tohru Masuyama, Yuji Miyamoto, Mitsumasa Oyanagi

The American journal of the medical sciences 333(5) 300-4 2007年5月

西向有沙

基本情報

論文

メニュー